ACADIA Pharmaceuticals Target Price Analysis by Brokerages
Sunday, 14 July 2024, 05:59
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Target Price Analysis
Learn about the $28.71 target price set by brokerages for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and its impact on the company's prospects.
Key Points:
- Target Price: $28.71
- Company: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
- Analysis: Brokerage Recommendations
Brokerages have carefully evaluated ACADIA Pharmaceuticals and provided a target price, shedding light on its future performance and investment potential.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.